Compare AMRX & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | AX |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2018 | 2004 |
| Metric | AMRX | AX |
|---|---|---|
| Price | $18.05 | $97.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $15.60 | ★ $103.14 |
| AVG Volume (30 Days) | ★ 2.1M | 394.0K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.19 | ★ 6.33 |
| Revenue | N/A | ★ $65,789,000.00 |
| Revenue This Year | $4.48 | $24.76 |
| Revenue Next Year | $7.13 | $10.86 |
| P/E Ratio | $92.18 | ★ $15.42 |
| Revenue Growth | N/A | ★ 1.78 |
| 52 Week Low | $7.67 | $74.89 |
| 52 Week High | $18.39 | $102.18 |
| Indicator | AMRX | AX |
|---|---|---|
| Relative Strength Index (RSI) | 67.85 | 55.20 |
| Support Level | $12.46 | $95.03 |
| Resistance Level | N/A | $100.42 |
| Average True Range (ATR) | 0.59 | 2.46 |
| MACD | -0.05 | -0.26 |
| Stochastic Oscillator | 80.15 | 31.47 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.